Special issues related to breast cancer adjuvant therapy in older women.

@article{Witherby2005SpecialIR,
  title={Special issues related to breast cancer adjuvant therapy in older women.},
  author={Sabrina M Witherby and Hyman Bernard Muss},
  journal={Breast},
  year={2005},
  volume={14 6},
  pages={600-11}
}
Increasing age remains the major risk factor for breast cancer and more than half of all breast cancers in North America and the European Union occur in women 65 years and older. Anticipated life expectancy, co-morbidity, and functional status must all be considered when offering systemic adjuvant treatment to older women. Tamoxifen significantly decreases… CONTINUE READING